How carnitine transporters boost reproductive health

Su­per­lu­mi­nal Med­i­cines, a start­up claim­ing that it can use ar­ti­fi­cial in­tel­li­gence to shrink the de­vel­op­ment of pre­clin­i­cal drug can­di­dates from years to a mat­ter of

Kin­nate Bio­phar­ma’s stock $KNTE soared 59% on Wednes­day af­ter­noon af­ter the Cal­i­for­nia drug de­vel­op­er dis­closed that two large share­hold­ers have ex­pressed in­ter­est in a take-pri­vate